Preoperative preparation of patients for aortic aneurysm surgery
Abstract
The paper presents the current practical knowledge of the pathogenesis of postoperative complications in aortic surgery. Recommendations on the tactics of treating patients and on their preoperative preparation are given in this article.
About the Authors
Yu. V. Belov
I.M. Sechenov First MSMU
Russian Federation
Russian Federation
Yuriy Vladimirovich Belov, MD, academician of RAMS, honoured scientist of Russia, director of the Research and educational clinical centre of aorta and interventional cardiology, prof., head of the chair of cardiovascular surgery and interventional cardiology
8–2 Trubetskaya str., Moscow, 119048
(495) 708–39–57
R. N. Komarov
I.M. Sechenov First MSMU
Russian Federation
Russian Federation
MD, deputy director in scientifi c work of the Research and educational clinical centre of aorta and interventional cardiology
I. A. Vinokurov
I.M. Sechenov First MSMU
Russian Federation
Russian Federation
doctor of the Clinic of heart, aortic and vascular surgery
References
1. Vasyuk Yu.A., Atroschenko E.S., Yuschuk E.N. Pleiotropic eff ects of statins — Basic Research under data // Serdce. 2006; 5: 228–237.
2. Vinokurov I.A., Bogopolskaya O.M., Charchyan E.R. et al. Molecular tools in the early (prenosological) diagnosis of aneurysms of large vessels // Kardiologiya i serdechno-sosudistaya khirurgiya. 2010; 2: 39–45.
3. Schukin Yu.V., Vachev A.N., Medvedeva E.A. et al. Prevention of cardiac complications due to aortoiliac reconstruction by correcting oxidative stress // Kardiologiya i serdechno-sosudistaya khirurgiya. 2010; 6: 16–19.
4. Ada W.Y. Chung, H. H. Clarice Yang, Marek W. Radomski. Long-Term Doxycycline Is More Eff ective Than Atenolol to Prevent Thoracic Aortic Aneurysm in Marfan Syndrome Through the Inhibition of Matrix Metalloproteinase-2 and -9. Circ. Res. 2008;102;e73-e85.
5. Bertrand M., Godet G., Fleron M.H. et al. Lumbar muscle rhabdomyolysis after abdominal aortic surgery. Anesth Analg 1997;85:11–15.
6. Boisseau N., Rabary O., Padovani B., et al. Improvement of ’dynamic analgesia’ does not decrease atelectasis after thoracotomy. Br J Anaesth. 2001;87(4):564-9.
7. Boucek R.J., Gunja-Smith Z., Noble N.L., Simpson C.F. Modulation by propranolol of the lysyl cross-links in aortic elastin and collagen of the aneurysm-prone turkey. Biochem Pharmacol. 1983;32:275–280,
8. Cartin-Ceba R., Sprung J., Gajic O., Warner D.O. The aging respiratory system: anesthetic strategies to minimize perioperative pulmonary complications. In: Silverstein J.H., Rooke G.A., Reves J.G., McLeskey C.H. Geriatric anesthesiology, 2nd edn. Springer, New York, 2007, pp 149–164.
9. Daugherty A., Manning M.W., Cassis L.A. Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol 2001;134:865–870.
10. Devereaux P.J., Chan M., Eikelboom J. Major vascular complications in patients undergoing noncardiac surgery: the magnitude of the problem, risk prediction, surveillance, and prevention. In: Yusuf S,Cairns JA, Camm AJ et al (eds) Evidence based cardiology, 3rd edn. BMJ Books, London, 2009, pp 47–6.
11. Etz C.D., Di Luozzo G., Bello R. et al. Pulmonary complications after descending thoracic and thoracoabdominal aortic repair: predictors, prevention, and treatment. Ann Thorac Surg 2007;83:870–876.
12. Fleisher L.A., Beckman J.A., Brown K.A. et al. ACC/ AHA Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 2007;50:1707–1732.
13. Fujiwara Y., Shiraya S., Miyake T. et al. Inhibition of experimental abdominal aortic aneurysm in a rat model by an angiotensin receptor blocker, valsartan. Int J Mol Med 2008;22:703–708.
14. Fochi O., Bignami E. et al. Cardiac protection by volatile anesthetics in non-cardiac surgery? A meta-analysis of randomized controlled studies on clinically relevant endpoints. HSR Proceedings in Intensive Care and Cardiovascular Anesthesia 2009;4:34–43.
15. Gadowski G.R., Pilcher D.B., Ricci M.A. Abdominal aortic aneurysm expansion rate: eff ect of size and beta-adrenergic blockade. J Vasc Surg. 1994;19:727–731.
16. Gal T.J. Pulmonary function testing. In: Miller RD (ed) Anesthesia, 4th edn. Churchill Livingstone,New York, 1994, vol I, ch 26, Roizen MF, Fleisher LA. Anesthetic implications of concurrent diseases. In: Miller RD (ed) Anesthesia, 4th edn. Churchill Livingstone, New York, 1994, vol I, ch 27.
17. Golub L.M., Lee H.M., Ryan M.E., Giannobile W.V., Payne J., Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple nonantimicrobial mechanisms. Adv Dent Res. 1998;12:12–26.
18. Graham I., Atar D., Borch-Johnsen K. et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 2007;28:2375–2414.
19. Jondeau G., Delorme G., Milleron O., Wilson J. Medical Aspect of the aortic disease: the follow up and its warnings. Thoracic aortic diseases. Springer 2006.
20. Habashi J.P., Judge D.P., Holm T.M. et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006; 312: 5770: 117—121.
21. Hackam D.G., Thiruchelvam D., Redelmeier D.A. Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case–control study. Lancet 2006;368:659–665.
22. Hindler K., Shaw A.D., Samuels J. et al. Improved postoperative outcomes associated with preoperativestatin therapy. Anesthesiology 2006;105:1260–1272.
23. Holmes D.R., Wester W., Thompson R.W., Reilly J.M. Prostaglandin E2 synthesis and cyclooxygenase expression in abdominal aortic aneurysms. J Vasc Surg 1997;25:810–815.
24. Jelcar J.M., Guitti C.S., Marson A.C., et al. Preoperative physiotherapy in prevention of pulmonary complications in pediatric cardiac surgery. Rev Bras Cir Cardiovasc 2008; 23(3): 383-388.
25. Judge D.P., Dietz H.C. Therapy of Marfan syndrome. Annual Review of Medicine 2008; 59: 43—59.
26. King V.L., Trivedi D.B., Gitlin J.M., Loftin C.D. Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice. Arterioscler Thromb Vasc Biol 2006;26: 1137–1143.
27. Koksoy C., LeMaire S.A., Curling P.E. et al. Renal perfusion during thoracoabdominal aortic operations: cold crystalloid is superior to normothermic blood. Ann Thorac Surg 2002;73:730–738.
28. Kor D.J., Brown M.J., Iscimen R. Peri-operative statin therapy and renal outcomes after major vascular surgery: a propensity-based analysis. J Cardiothorac Vasc Anesth 2008;22:210–216.
29. Lacro R.V., Dietz H.C., Wruck L.M. Pediatric Heart Network Investigators. Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome . Am Heart J 2007; 154: 4: 624—631.
30. Lawrence V.A., Hilsenbeck S.G., Mulrow C.D. et al. Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery. Journal of General InternalMedicine 1995;10(12):671–8.
31. Lawrence V.A., Cornell J.E., Smetana G.W. Strategies to reduce postoperative complications after noncardiac surgery: systematic review for the American College of Physicians. Ann Intern Med 2006; 144:596–608.
32. Leach S.D., Toole A.L., Stern H. et al. Eff ect of beta-adrenergic blockade on the growth rate of abdominal aortic aneurysms. Arch Surg. 1988;123:606–609.
33. Liao S., Miralles M., Kelley B.J. et al. Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. J Vasc Surg 2001;33: 1057–1064.
34. Matt P., Habashi J., Carrel T. Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan? J Thoracic Cardiovasc Surg 2008; 135: 2: 389—394.
35. Merten G.J., Burgess W.P., Gray L.V. et al. Simonton CA 3rd Rittase RA, Norton HJ, Kennedy TP: Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA291:2328– 2334,2004.
36. Rittase R.A., Norton H.J., Kennedy T.P.: Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA291:2328–2334,2004. Mochizuki S., Dahlo¨f B., Shimizu M., et al. Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, openlabel, blinded endpoint morbidity–mortality study. Lancet 2007;369: 1431–1439.
37. Naka T., Jones D., Baldwin I. et al. Myoglobin clearance by super high-fl ux hemofi ltration in a case of severe rhabdomyolysis: a case report. Crit Care 2005;9:R90–95.
38. O’Brien M.M., Gonzales R., Shroyer A.L. et al. Modest serum creatinine elevation aff ects adverse outcome after general surgery. Kidney Int 2002;62:585–592.
39. Petrinec D., Liao S., Holmes D.R. et al. Doxycycline inhibition of aneurysmal degeneration in an elastaseinduced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg. 1996;23:336–346.
40. Poldermans D., Bax J.J., Boersma E. et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol 2010;27:92–137.
41. Powell J.T., Worrell P., MacSweeney S.T. et al. Smoking as a risk factor for abdominal aortic aneurysm. Ann N Y Acad Sci. 1996;800:246–248.
42. Prall A.K., Longo G.M., Mayhan W.G. et al. Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and eff ect on aneurysm growth in mice. J Vasc Surg. 2002;35:923–929.
43. Propranolol for small abdominal aortic aneurysms: results of a randomized trial. J Vasc Surg. 2002;35:72–79.
44. Qaseem A., Snow V., Fitterman N. et al. Clinical effi cacy assesment subcommittee of American College of Physicians. risk for and reduction of pulmonary complications in patients undergoing noncardiothoracic surgery: an American College of Physicians guideline. Ann Intern Med 2006;144:575–580.
45. Rios A.S., Silber E.N., Bavishi N. Eff ect of long-term betablockade on aortic root compliance in patients with Marfan syndrome. Am Heart J 1999; 137: 6: 1057—1061.
46. Rosenson R.S., Tangney C.C. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA 1998;279:1643–1650.
47. Rossi-Foulkes R., Roman M.J., Rosen S.E. et al. Phenotypic features and impact of beta blocker or calcium agonist therapy on aortic lumen size in the Marfan syndrome. Am J Cardiol 1999; 83:1364—1368.
48. Rudra A., Sudipta D. Postoperative pulmonary complications. Indian J Anaesth 2006;50(2):89–98.
49. Schouten A., Dunkelgrun O., Feringa M. et al. Myocardial damage in high-risk patients undergoing elective endovascular or open infrarenal abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2007;33:544–549.
50. Sharkey A.M. Cardiovascular Management of Marfan Syndrome in the Young. Current Treatment Options of Cardiovascular Medicine 2006; 8: 5: 396—402.
51. Shores J., Berger K.R., Murphy E.A., Pyeritz R.E. Progression of aortic dilatation and the benefi t of long-term beta-adrenergic blockade in Marfan’s syndrome. N Engl J Med 1994; 330 . 1335—1341.
52. Solomon R., Werner C., Mann D. et al. Eff ects of saline, mannitol and furosemide to prevent acute decreasesin renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416–1420.
53. Srodon P., Matson M., Ham R. Contrast nephropathy in lower limb angiography. Ann R Coll Surg Engl 2003;85:187–191.
54. Warner D.O., Warner M.A., Off ord K.P. et al. Airway obstruction and perioperative complications in smokers undergoing abdominal surgery. Anesthesiology 1999;90:372–379.
55. Welten G.M., Chonchol M., Schouten O. et al. Statin use is associated with early recovery of kidney injury after vascular surgery. Nephrol Dial Transplant 2008;23:3867–3873.
56. Wij eysundera D.N., Beattie W.S. Calcium channel blockers for reducing cardiac morbidity after noncardiacsurgery: a meta-analysis. Anesth Analg 2003;97:634–641.
Review
Views: 43
Email this article 